Stewardship

This report presents the estimates of the significant financial contributions of the biotechnology industry to the U.S. economy and to revenues collected by the federal, state and local governments.

At BIO’s recent Focus on Compliance workshop, participants learned about the responsible use of plant biotechnology during R&D.

BIO hosted a successful special session on August 20th where the first public presentation was made of the BIO Guidance on Genetically Engineered (GE) Animal Stewardship with 100 international scientists and government officials in the audience of the 7th Transgenic Animal Conference, Tahoe, Calif.

Today’s program at the 7th Transgenic Animal Research Conference in Tahoe, Calif., hit the “hot science”, as one researcher from Germany noted during lunch. The research on genetically engineered (GE) animals will reap huge dividends in societal benefits to solve the world’s most pressing challenges.

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

Today, the biotechnology industry is enjoying more success and influence than ever before. Our industry’s innovations continue to improve the lives of people worldwide, and the advancement of these innovations is supported by the work of BIO.

Letters, Testimony & Comments

January 24 2013
Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are...
October 4 2010
Dear Secretary Vilsack: For the past 15 years, agricultural products derived from modern biotechnology have provided significant...
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the proposed regulations to implement...

Press Releases

June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
March 2 2012
WASHINGTON, D.C. (March 2, 2012) – The Biotechnology Industry Organization (BIO) announced today that it has...
February 9 2012
Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry...
October 13 2011
Washington, D.C. (October 13, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood...
October 7 2011
Washington, D.C. (October 7, 2011) – In a case brought against USDA’s Animal and Plant Health Inspection...